# MediTech Chronicles ## Posts - [Integrating FDA PCCP into Your Medical Device QMS: A 10-Point Checklist for QMSR & ISO 13485](https://meditechchronicles.com/2026/08/fda-pccp-iso-13485.html): Learn how to execute FDA PCCP QMS integration successfully. Discover a 10-point checklist for aligning AI medical device change control with QMSR and ISO 13485. - [ISO 42001 vs ISO 13485: How to Build an AI Medical Device QMS](https://meditechchronicles.com/2026/07/iso-42001-vs-iso-13485-ai-medical-device-qms.html): Published July 2026 | Practical guidance for medical-device founders, QA/RA leaders, software teams, and AI governance owners. ISO 42001 vs ISO 13485 is not a choice between two competing quality standards. ISO 13485:2016 is the regulated medical-device quality management system backbone. ISO/IEC 42001:2023 is an organization-wide artificial intelligence management system standard that adds governance for how AI is developed, supplied, deployed, monitored, and improved. For an AI-enabled medical device, the practical answer is usually integration: retain ISO 13485 for the device QMS, connect it to ISO 14971 risk management and the applicable software lifecycle controls, then add ISO/IEC 42001 processes for ... Read more - [EU AI Act vs FDA SaMD Compliance: 7 Critical Wins](https://meditechchronicles.com/2026/06/eu-ai-act-vs-fda-samd-compliance.html): Let me be direct: EU AI Act vs FDA SaMD compliance is the most consequential dual-regulatory challenge facing digital health startups right now. Not eventually. Right now, in 2026, with the AI Act’s high-risk provisions fully operative. FDA’s Predetermined Change Control Plan (PCCP) guidance is simultaneously reshaping how machine-learning-enabled devices are reviewed on the US side. The companies that treat these two frameworks as parallel but separate workstreams are burning runway and courting enforcement risk. The ones that architect a unified compliance posture from day one are moving faster, spending less, and walking into notified body audits with something rare: confidence. ... Read more - [RPM Cybersecurity 2026: FDA 524B Mandates & SBOM Compliance](https://meditechchronicles.com/2026/05/rpm-cybersecurity-2026-fda-524b-mandates-sbom-compliance.html): The RPM Cybersecurity Shift: Navigating New FDA Mandates and Software Supply Chain Transparency in 2026 A Senior Cybersecurity Architect’s Field Guide — Because “We Think We’re Covered” Is No Longer Good Enough May 2026  |  30-minute read  |  Written for C-Suite, Regulatory Affairs, and QA Leadership 📋 Table of Contents The Confidence Paradox: Why 90% Confidence Masks a 50% Coverage Gap The FDA Mandate Reality: Section 524B Is Not a Suggestion Anymore RPM Cybersecurity 2026: How CMS Expansion Created a New Attack Surface SBOM in 2026: From Compliance PDF to Quality System Backbone Comparison Table: Pre-2026 vs. The 2026 Mandatory Framework ... Read more - [QMSR Transition Success: The Definitive FDA 21 CFR 820 & ISO 13485 Guide (2026)](https://meditechchronicles.com/2026/04/qmsr-transition-fda-21-cfr-820-iso-13485.html): QMSR Transition: Harmonizing FDA 21 CFR 820 with ISO 13485:2016 — Post-Implementation Guide 2026 A post-implementation compliance and inspection readiness guide for medical device manufacturers — April 2026 Updated April 2026 | 18-minute read | FDA QMSR, ISO 13485:2016, CP 7382.850, ISO 14971 risk management Table of Contents The Day the QSR Died — How FDA 21 CFR Part 820 and ISO 13485 Finally Merged Why the FDA Finally Made This Move Incorporation by Reference: What It Actually Means in Practice The Core Difference Between ISO 13485 and 21 CFR 820 The Terminology Shift: Legacy QSR vs. New QMSR ISO 14971 ... Read more - [AI Drug Combination Discovery: 2026 Pharma Leader’s Guide](https://meditechchronicles.com/2026/04/ai-drug-combination-discovery-2026-pharma-leaders-guide.html): The AI Drug Combination Discovery: 2026 Pharma Leader's Guide provides an in-depth overview of the transformative impact of artificial intelligence on pharmaceutical development. With advancements in AI drug combination discovery, particularly through machine learning in pharma, the guide highlights the importance of computational drug combinations for optimising therapeutic efficacy. The incorporation of graph neural network drug synergy and digital twin pharma technologies facilitates enhanced drug synergy prediction AI, paving the way for innovative AI-driven combination therapy approaches. Furthermore, the exploration of quantum-classical hybrid drug discovery and multimodal AI pharma underscores the future of AI oncology drug combinations, positioning stakeholders to remain competitive in the evolving landscape. - [AI in Healthcare: Diagnostics, Imaging & Surgery](https://meditechchronicles.com/2026/03/ai-in-healthcare-diagnostics-imaging-surgery.html): AI Integration in Healthcare: Diagnostics, Imaging, Remote Monitoring & Surgical Tools — A Deep-Dive for Clinicians and Industry Professionals Updated March 2026 | 25-minute read | Peer-reviewed sources & real-world deployment data 📋 What You’ll Find in This Article The Integration Moment: Where Things Actually Stand in 2026 AI-Powered Diagnostics: Beyond the Buzzword Medical Imaging AI: From “Reading Help” to Full Diagnostic Orchestration Remote Patient Monitoring: The Shift from Reactive to Predictive Care AI in Surgical Tools: What the OR Actually Looks Like Today What Most People Don’t Know: Underutilized AI Capabilities Worth Exploring The Data Quality Crisis — AI’s Biggest ... Read more - [AI Safety 2026: The New Pharma Standard](https://meditechchronicles.com/2026/03/ai-safety-2026-the-new-pharma-standard.html): AI Safety 2026: The New Pharma Standard – Regulated AI & Model Drift Monitoring AI Safety 2026: The New Pharma Standard – A comprehensive guide to regulated AI systems, model drift monitoring, and pharmaceutical compliance The pharmaceutical and medical device industries have officially moved past the “experimentation phase” of Artificial Intelligence. In boardrooms from Basel to Boston, the conversation has shifted from “Can AI help us?” to the more pressing question: “Is our AI safe, regulated, and ready for a clinical audit?” By end of 2025, the FDA had approved or cleared 1,016 medical devices using AI/ML technologies-nearly double the number ... Read more - [The Critical EU MedTech Innovation Pressure: Navigating 2026 MDR & EY-DG SANTE Updates.](https://meditechchronicles.com/2026/01/eu-medtech-innovation-mdr-ivdr-2026-ey-dg-sante-updates.html): The EU MedTech Innovation Pressure: Navigating 2026 “Crunch” and EY-DG SANTE Findings For years, the European Union was the global launchpad for EU MedTech Innovation, but recent data suggests a pivotal identity crisis is looming. A “CE Mark” was often the first major milestone for a startup before tackling the FDA. However, the tide has turned. As we move deeper into the mid-2020s, the medical technology landscape is facing a pivotal identity crisis.  The recent EY-DG SANTE study, commissioned by the European Commission, has provided the data to back up what many MedTech professionals have been whispering in boardrooms: the regulatory ... Read more - [The Future of AI in Pharmaceuticals & Medical Devices (2026 Review)](https://meditechchronicles.com/2026/01/future-of-ai-in-pharmaceuticals-medical-devices.html): The Future of Healthcare: How AI is Revolutionizing the US Pharmaceutical and Medical Device Industry (2026 Edition) The pharmaceutical and medical device landscape in the United States is undergoing its most significant transformation since the digital revolution. In 2025, Artificial Intelligence (AI) is no longer a “future concept”—it is the primary driver of efficiency, safety, and personalized patient care. The numbers tell the story: The global market for AI in healthcare is projected to breach $45 billion by the end of 2025, with the US market leading the charge. From accelerating drug discovery cycles to navigating complex FDA regulatory frameworks, AI ... Read more - [AI Solubility Prediction & 2026 Formulation Trends](https://meditechchronicles.com/2026/01/ai-solubility-prediction-2026-formulation-trends.html): If you are a pharmacy student or a researcher in 2026, the old textbooks aren’t telling you the whole story. For decades, we learned that solubility was simple: “Like dissolves like.” We memorized the Noyes-Whitney equation, looked at a solubility chart, and mixed powders in a beaker. But today, that approach is obsolete. With 90% of new drug candidates classified as “poorly soluble” (BCS Class II and IV), the industry faces an “insolubility crisis.” The modern lab doesn’t just “dissolve” drugs; it engineers them. We use Artificial Intelligence to predict solubility limits before a molecule is even synthesized. We use lasers ... Read more - [AI in Indian Pharma 2025: Trends, Stats & Future Outlook](https://meditechchronicles.com/2025/12/ai-in-indian-pharma-trends-stats-future-outlook.html): The 74% Tipping Point: Why Indian Pharma is Going “All-In” on AI If you picked up the newspaper this week, you might have seen a striking statistic that should make every pharmaceutical executive sit up and take notice. A recent report highlights that 74% of Indian business leaders now rank Artificial Intelligence (AI) as their top technology adoption choice for 2025. This isn’t just a “tech trend.” It is a massive divergence from the global average, where only about 55% of leaders prioritize AI with the same intensity. For those of us in the pharmaceutical and medical device sectors, this number ... Read more - [How Does a Smartwatch ECG Differ from a Clinical ECG? (Comparison)](https://meditechchronicles.com/2025/12/how-does-a-smartwatch-ecg-differ-from-a-clinical-ecg-comparison.html): You feel a flutter in your chest. You look down at your wrist, tap an app, and thirty seconds later, your smartwatch tells you it detects signs of Atrial Fibrillation (AFib). It’s a technological marvel right on your wrist. But when you arrive at the emergency room, the first thing they do is hook you up to a large machine with wires strapped all over your chest for another ECG. Why? If your watch already gave you an answer, why do doctors need the hospital machine? Understanding the difference between these two technologies is vital. One is an incredibly useful alarm ... Read more - [AI in Healthcare: Revolutionizing Modern Diagnostics](https://meditechchronicles.com/2025/08/ai-in-healthcare-revolutionizing-modern-diagnostics.html): Artificial Intelligence in Healthcare: A Global Guide to AI-Powered Medical Innovation (2026 Update) Updated March 2026 | 18-minute read | Verified with latest clinical data & real-world case studies 📋 In This Article Introduction — Buzzword or Breakthrough? AI Basics: What Are We Really Talking About? The 2026 Market Reality: Numbers That Matter The Ambient AI Scribe Revolution AI-Powered Diagnostics: Catching What Human Eyes Miss AI in Drug Discovery & Clinical Trials Precision Medicine & Genomics Administrative AI: The Silent Efficiency Engine Global Perspectives: How Other Nations Are Deploying AI Ethics, Bias & the Big Questions The Road Ahead: What 2026 ... Read more - [Patient-Centric Design in MedTech: Better UX](https://meditechchronicles.com/2025/03/patient-centric-design-in-medtech-better-ux.html): Patient-Centric Design in Medical Devices: Enhancing Usability & Patient Care In the world of healthcare, the phrase “patient-centric care” often gets thrown around, but what does it really mean? At its core, it’s about designing medical devices and systems that focus on the needs, preferences, and experiences of patients rather than just focusing solely on the technical aspects. As we innovate and advance in medical technology, adopting a patient-centric approach becomes increasingly important. But how does this approach manifest in medical devices? Let’s dive in..! What is Patient-Centric Design? Patient-centric design involves developing medical devices with the patient’s experience at the ... Read more - [Alembic seeks to mix it with US and European players](https://meditechchronicles.com/2024/05/alembic-seeks-to-mix-it-with-us-and-european-players.html): Alembic seeks to mix it with US and European players Indian pharmaceutical firm Alembic is seeking to expand its presence in the lucrative US and European drug markets through an expanded partnering programme.  The Gujarat-headquartered group, which is involved in both the active pharmaceutical ingredient (API) and pharmaceutical formulation markets, aims to grow internationally and double its annual turnover over the next two to three years, according to a report in India’s Business Standard. Company director Pranav Amin explained that the firm intends to file about 10-12 ANDAs every year and to tap potential in the generic markets of the US ... Read more - [Medical Robotics: Enhancing Surgical Procedures and Patient Outcomes](https://meditechchronicles.com/2024/03/medical-robotics-enhancing-surgical-procedures-and-patient-outcomes.html): MEDICAL ROBOTICS: Enhancing Surgical Procedures and Patient Outcomes The advent of medical robotics has revolutionized the way surgical procedures are performed, offering unprecedented precision and control. This transformative technology has not only enhanced the capabilities of surgeons but also significantly improved patient outcomes. The technology continues to revolutionize the way surgeries are performed, leading to improved patient outcomes and enhanced precision. One such groundbreaking innovation is the integration of medical robotics into surgical procedures. This blog post investigates the transformative impact of medical robotics, exploring how it enhances surgical procedures and benefits patients. The Rise of Robotic Surgery: Robotic surgery, also ... Read more - [How to Avoid H1N1 Virus](https://meditechchronicles.com/2024/03/how-to-avoid-h1n1-virus.html): How to Avoid H1N1: Tips and Tricks to Stay Safe from the Pandemic Virus H1N1 is a pandemic virus that affected many people across the globe. It can cause severe illness and sometimes even lead to death. Fortunately, there are steps you can take to avoid getting infected with this virus. In this article, we will discuss some additional tips and tricks that you can follow to stay safe from H1N1. Steps: 1. Know the Symptoms: Some symptoms of swine flu are Shortness of breath, High fever (over a hundred Fahrenheit or 40 Celsius), unusual tiredness (dizziness), runny nose, sore throat, ... Read more - [Green Initiatives in India: Sustainable Pharma Manufacturing](https://meditechchronicles.com/2023/10/green-initiatives-in-india-sustainable-pharma-manufacturing.html): GREEN INITIATIVES IN INDIA: Sustainable Practices in Pharma Manufacturing In an age where environmental concerns are at the forefront of global discussions, every industry must take responsibility for its carbon footprint. The pharmaceutical manufacturing sector, in particular, has been under scrutiny for its environmental impact due to energy-intensive processes and waste generation. However, the industry is increasingly embracing sustainable practices, focusing on green initiatives to reduce its environmental footprint. In this article, we will delve into the world of sustainable pharma manufacturing, with a special focus on green initiatives in India. Green initiatives in India’s pharma manufacturing refer to sustainable practices ... Read more - [Role of Blockchain in Healthcare Data Management (2026 Guide)](https://meditechchronicles.com/2023/09/role-of-blockchain-in-healthcare-data.html): Posts Updated in 2026 – This article reflects the latest developments in blockchain, healthcare interoperability, AI integration, and global regulatory trends. The healthcare industry is undergoing a fundamental shift toward digital-first, data-driven care. As electronic health records, AI diagnostics, and remote care expand, the need for secure, interoperable, and trustworthy data management has never been greater. In 2026, blockchain technology is emerging as a foundational layer for healthcare data management, not as a trend, but as an infrastructure solution. What Is Blockchain in Healthcare? Blockchain is a decentralized, cryptographically secured digital ledger that records transactions across multiple nodes. In healthcare, blockchain ... Read more - [PRECISION MEDICINE : Personalizing Healthcare with Genomics](https://meditechchronicles.com/2023/09/precision-medicine-personalizing-healthcare-with-genomics.html): PRECISION MEDICINE: Personalizing Healthcare with Genomics What if your doctor could prescribe a treatment that is tailored to your unique genetic makeup, lifestyle and environment? That is the promise of precision medicine, an emerging field that uses genomics and other data to create personalized healthcare plans. Precision medicine is not a new concept. For decades, doctors have been using blood type, allergies and other factors to customize treatments for patients. However, with the advances in genomic sequencing and data analysis, precision medicine has become more feasible and affordable than ever before. In the realm of healthcare, one size does not fit ... Read more - [Emerging Trends in Digital Health - Wearables and IoT Devices](https://meditechchronicles.com/2023/08/digital-health-wearables-and-iot.html): The healthcare industry stands at an inflection point. Wearable medical devices have transitioned from consumer novelties to clinical-grade tools, with the global market reaching USD 42.7 billion in 2024 and expected to exceed USD 152 billion by 2029, according to Grand View Research. But the real story isn’t the market size—it’s the fundamental shift in how care is delivered. For the first time in medical history, continuous, non-invasive monitoring of patients outside clinical settings is becoming standard practice rather than exception. Remote patient monitoring (RPM) powered by IoT wearables is reducing hospital readmissions for chronic disease management, enabling early detection of acute episodes, and ... Read more - [Drug Solubility Guide 2026: Essential Formulas & Charts](https://meditechchronicles.com/2023/08/drug-solubility-formulas-charts.html): Drug Solubility Guide 2026: Essential Formulas & Charts A practical pharmaceutical science guide to drug solubility, dissolution rate, formulation development, and delivery-system optimization. In pharmaceutical development, drug solubility is one of the most important properties influencing a drug’s bioavailability, therapeutic efficacy, formulation stability, and delivery route. A drug must dissolve at a suitable rate and concentration before it can be absorbed and produce the intended clinical effect. Understanding drug solubility is crucial for effective drug development and delivery. Solubility, the ability of a substance to dissolve in a solvent, plays a pivotal role in determining a drug’s bioavailability, efficacy, and even ... Read more - [AI Drug Discovery in 2026: 7 Powerful Strategies Transforming Pharma R&D](https://meditechchronicles.com/2023/08/ai-drug-discovery-pharma.html): AI Drug Discovery in 2026: 7 Powerful Strategies Transforming Pharma R&D The integration of AI drug discovery has swiftly transformed the global pharmaceutical industry. The traditional research and development (R&D) process is notoriously lengthy, resource-intensive, and marked by high clinical failure rates. However, artificial intelligence promises to revolutionize the drug development pipeline. For decision-makers looking to maximize ROI and speed to market, understanding this technological shift is no longer optional—it is a competitive necessity. This article delves into the nuances of AI in drug discovery, exploring how it is reshaping pharma R&D processes, aligning with global regulatory standards, and accelerating the ... Read more - [Common Health Issues in the Current generation & Health Tips](https://meditechchronicles.com/2023/07/common-health-issues-in-the-current-generation-health-tips.html): Common Health Issues in the Current Generation & Health Tips In today’s fast-paced and technology-driven world, the health landscape has undergone significant transformations, giving rise to a host of new challenges for the current generation. As we navigate the complexities of modern life, it is essential to understand and address the common health issues that plague our society. From the physical consequences of sedentary lifestyles and poor nutrition to the mental and emotional toll of stress and digital overload, this blog post aims to shed light on the prevalent health concerns faced by the current generation. By exploring these issues and ... Read more - [Behavioral Innovations 2026: The Future of MedTech & Patient Psychology](https://meditechchronicles.com/2023/07/power-of-behavioral-innovations.html): Discover how behavioral innovations, digital nudging, and predictive neuro-analytics are transforming MedTech and patient psychology in 2026. - [INNOVATIONS IN MEDICAL DEVICES : Revolutionizing Healthcare](https://meditechchronicles.com/2023/07/innovations-in-medical-devices.html): INNOVATIONS IN MEDICAL DEVICES: Revolutionizing Healthcare In recent years, the field of medical technology has witnessed a remarkable surge in innovation. From advanced imaging systems to wearable devices and robotic surgical tools, these groundbreaking medical devices are transforming healthcare delivery and improving patient outcomes. Innovations in medical devices have not only revolutionized the way we diagnose and treat diseases but also enhance the overall patient experience. This article explores some of the remarkable innovations in medical devices that are shaping the future of healthcare. 1. Robotics and Surgical Innovations: Robotic-assisted surgery has revolutionized the field of minimally invasive surgery. Surgical robots ... Read more - [Lilly sells R&D campus to Covance in the pioneering deal.](https://meditechchronicles.com/2008/09/lilly-sells-rd-campus-to-covance.html): Lilly sells R&D campus to Covance in the pioneering deal.. Yesterday, Eli Lilly made a significant step toward outsourcing with the sale of a significant R&D site to contract research group Covance and the formation of new contracts with Quintiles and i3.  Lilly is adopting a road that is less usual in R&D but is already well-trodden in the pharmaceutical manufacturing industry. When faced with excess capacity, several pharmaceutical companies chose to sell off operations, frequently including legacy contracts, to management buyout teams or reputable contract manufacturers. The Lilly/Covance deal is one of the first large-scale examples of this type of ... Read more - [Dr Reddy's in collaboration with SkyePharma on delivery system](https://meditechchronicles.com/2008/09/dr-reddys-in-collaboration-with-skyepharma.html): Dr Reddy’s in collaboration with SkyePharma on delivery system Using two of SkyePharma’s unique drug delivery systems, the UK company SkyePharma has agreed to conduct a feasibility study on an unnamed product with Dr Reddy’s Laboratories of India. The study’s expenses will be covered by Dr. Reddy’s, and SkyePharma will also get a “small” up-front payment, according to the two businesses. Full development activities would start later this year, they stated, if the feasibility study is successful.  With organizations like GlaxoSmithKline, Roche, Schiele, Novartis, AstraZeneca, Nitec, and Abbott in the past, SkyePharma has collaborated on the development of both licensed pharmaceuticals ... Read more - [Researchers target ocular drug delivery market](https://meditechchronicles.com/2008/09/researchers-target-ocular-drug-delivery-market.html): Researchers target ocular drug delivery market Researchers have developed a drug delivery device which attaches to the eye and could negate the need for repeat injections. The team from the University of Southern California has created a simple polymer device which is inserted under the conjunctiva and delivers a therapeutic to the affected area. In time the device could come to replace the intravitreal injections which patients suffering from glaucoma and related eye diseases currently have to be administered with.  Ellis Meng, researcher on the project, was keen to emphasise further refinements are in the pipeline. She said: “This prototype isn’t ... Read more - [Competition intensifying for diabetes subjects; Acurian](https://meditechchronicles.com/2008/09/competition-intensifying-for-diabetes-subjects-acurian.html): Competition intensifying for diabetes subjects; Acurian Acurian, a company that specializes in patient recruiting, has reached a significant business milestone with the addition of more than 50 percent of the country’s type 2 diabetes population to its database.  Approximately 8 million of the estimated 16 million diagnosed type 2 or adult-onset diabetes are already on the company’s books. The business maintains a database of almost 40 million patients in total. According to Rick Malcolm, PhD, CEO of Acurian, “It should come as no surprise that diabetes is one of the most strong indications in our database. However, given the fierce rivalry ... Read more - [Sun Pharma eyes tie-ups in Europe](https://meditechchronicles.com/2008/09/sun-pharma-eyes-tie-ups-in-europe.html): Sun Pharma eyes tie-ups in Europe DRUG major Sun Pharmaceuticals Industries Ltd is looking for partnerships in the European market to fuel its next level of growth in the international arena.  The company, however, has dropped its plans to raise funds of about $350 million through a foreign currency convertible bond issue. To support the company’s domestic and export plans, an investment of about Rs 100 crore has been earmarked towards beefing up capacity.  A bulk of the amount would go into capacity expansion at Sun Pharma’s facilities in Panoli and Ahmednagar, part of it would also go towards Sun’s Halol ... Read more - [FDA lists drugs with potential safety issues](https://meditechchronicles.com/2008/09/fda-lists-drugs-with-potential-safety-issues.html): FDA lists drugs with potential safety issues A list of drugs currently being evaluated for potential safety issues by the US Food and Drug Administration (FDA) has been posted on its website. The list has been published under laws brought in last September that require the FDA to inform the public of new safety information or potential signals of serious risk. Information is to be published each quarter detailing drugs that have been identified as having potential safety issues based on reports in the FDA’s Adverse Event Reporting System (AERS). The list is intended to inform patients of potential safety issues and the ... Read more - [Sandoz boosts Canadian production capacity](https://meditechchronicles.com/2008/09/sandoz-boosts-canadian-production-capacity.html): Sandoz boosts Canadian production capacity Sandoz Canada, a unit of Novartis’ generics arm, has opened a second manufacturing plant at its site in Boucherville, Quebec, boosting local production capacity 66 per cent. The plant, which is due to be fully operational by mid September, comprises manufacturing, laboratory and warehousing space that the firm believes will give it the flexibility it needs to keep pace with increasing market demands.  Richard Saynor, Head of Commercial Operations for Asia-Pacific, Latin America, Canada and Turkey says that: “The new plant in Boucherville is highly significant for our Canadian operations, and for Sandoz worldwide. It will ... Read more - [Cholesterol- lowering drug given cancer all-clear](https://meditechchronicles.com/2008/09/cholesterol-lowering-drug-given-cancer-all-clear.html): Cholesterol- lowering drug given cancer all-clear Cancer fears about a cholesterol- lowering drug have turned out to be a ‘statistical blip’. A class of cholesterol- lowering drug that had been implicated in a cancer scare has been cleared by epidemiologists using the results from two large ongoing clinical trials.  Preliminary results from the relatively small SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study had triggered the cancer scare in July. The trial was designed to investigate whether a combination of these two cholesterol- lowering drugs would help in cases of aortic stenosis, where a key heart valve is partially blocked. Simvastatin, ... Read more - [Big pharma's pre-competitive collaboration](https://meditechchronicles.com/2008/08/big-pharmas-pre-competitive-collaboration.html): Big pharma’s pre-competitive collaboration Merck, Eli Lilly and Pfizer have provided funding to launch Enlight Biosciences, a for-profit venture that aims to advance breakthrough technologies for drug discovery and development. The lowdown: There has recently been increasing emphasis from industry on participating in non-profit collaborations to address issues in drug development that are considered to be pre-competitive.  Now, Merck, Eli Lilly and Pfizer, together with the venture capital firm PureTech Ventures and several leading academic researchers, have founded Enlight Biosciences.  This is a for-profit venture that will aim to tackle critical unmet industry needs with innovations from academia and start-up companies. ... Read more ## Pages - [Disclaimer & Terms of Service](https://meditechchronicles.com/disclaimer-terms-of-service): Disclaimer & Terms of Service Last Updated: April 2026 1. General Disclaimer The content provided on MediTech Chronicles (“the Site”) is for informational and educational purposes only. While we strive to provide accurate, current, and well-researched information about the pharmaceutical, medical device, and healthcare industries, the Site and all content are provided “AS IS” without warranty of any kind, express or implied. 2. Not Professional Advice The content on MediTech Chronicles does not constitute legal, medical, regulatory, financial, or professional advice of any kind. Articles, blog posts, and resources are not substitutes for consultation with qualified professionals. Before making business, clinical, ... Read more - [Privacy Policy](https://meditechchronicles.com/privacy-policy): Privacy Policy Last Updated: April 2026 1. Introduction MediTech Chronicles is committed to protecting your privacy. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website and blog at meditechchronicles.blogspot.com (the “Site”), including all related mobile applications. Please read this Privacy Policy carefully. If you do not agree with our policies and practices, please do not use our Site. By accessing and using MediTech Chronicles, you acknowledge that you have read, understood, and agree to be bound by all the terms of this Privacy Policy. 2. Information We Collect A. Information You Provide ... Read more - [Contact Us](https://meditechchronicles.com/contact-us): Contact Us We’d love to hear from you! Have questions, suggestions, or feedback about MediTech Chronicles? Please don’t hesitate to reach out using the contact method below. Contact Information Email: meditechchronicles@gmail.com Inquiry Categories General Inquiries & Feedback Have comments about our content? Noticed an error? Want to suggest a topic? We welcome constructive feedback that helps us improve MediTech Chronicles. Please share your thoughts in your email to meditechchronicles@gmail.com Advertising & Partnership Inquiries Are you interested in guest posting, or collaborative opportunities? We’re open to partnerships that align with our mission of delivering quality pharmaceutical and healthcare industry content. Please outline ... Read more - [About the Author | The Mission](https://meditechchronicles.com/about-the-author-the-mission): About MediTech Chronicles Welcome to MediTech Chronicles – Your Premier Hub for Pharmaceutical, Medical Device, and Healthcare Industry Insights At MediTech Chronicles, the primary objective is to deliver cutting-edge information, strategic insights, and analytical deep-dives across the pharmaceutical, medical device, and healthcare technology industries. In an era where global healthcare frameworks are shifting rapidly under the influence of digital transformation, this platform serves as a vital bridge connecting technical breakthroughs with regulatory execution. This blog operates as a trusted, authoritative resource for industry professionals navigating complex regulatory frameworks, clinical researchers tracking development milestones, healthcare entrepreneurs launching innovative startups, and dedicated pharmacy ... Read more ## Optional - [Agent (MCP protocol)](websites-agents.hostinger.com/meditechchronicles.com/mcp) [comment]: # (Generated by Hostinger Tools Plugin)